GlaxoSmithKline Press Releases
Breaking News
-
How to best standardise imaging result from multi centre clinical trials
SMi present their 8th annual conference on......... Imaging in Cancer Drug Development 14-15 March 2012, Copthorne Tara Hotel, London /EINPresswire.com/ The number of patients diagnosed with cancer worldwide each year is estimated to be...
-
Understand the Strategies and developments in Pharmaceutical Parallel Trade
/EINPresswire.com/ SMi is proud to present their 6th annual Pharmaceutical Parallel Trade Conference, taking place on 6th & 7th February 2012 at the Copthorne Tara Hotel in London. This year's event will bring together expert speakers from different...
-
Advances and Progress in Drug Design - Discover the latest developments
/EINPresswire.com/ SMi are proud to present the 11th annual Advances and Progress in Drug Design conference, taking place on 20th & 21st February 2012 at Copthorne Tara Hotel in London, UK. The number of pharmaceutical products entering the...
-
Europe's Leading Pre-Filled Syringes conference
/EINPresswire.com/ Europe's Leading Pre-Filled Syringes conference, taking place on 18th & 19th January 2012 at Marriott Regents Park in London, UK Now in its 4th year it promises to be bigger and better! Building on the continual success...
-
Biomarkers Summit - Discovery, Development & Therapeutics
/EINPresswire.com/ SMi proudly presents their 5th annual Biomarkers Summit, taking place on 16th & 17th January at Copthorne Tara Hotel in London, UK. This year's exciting event will provide a complete picture of developments in the biomarkers...
Press Releases
GlaxoSmithKline
-
Arch Biopartners Appoints Claude Allary as Special Advisor
Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) announced today Claude Allary has been appointed Special Advisor to the Company. In this capacity, Mr. Allary will provide expertise in evaluating commercial opportunities...
-
Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors
Editors note: There is a photo associated with this press release. Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB) (the "Company"), a biotechnology company specializing in carbohydrate chemistry technology, announced...
-
Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo PR Newswire CHICAGO , Dec. 29, 2011 /PRNewswire/ -- Today, Zacks Equity Research discusses the Pharma & Biotech, including Vertex Pharma...
-
The Zacks Analyst Blog Highlights: GlaxoSmithKline, Roche, Nabors Industries, Patterson-UTI Energy and Ensco plc
The Zacks Analyst Blog Highlights: GlaxoSmithKline, Roche, Nabors Industries, Patterson-UTI Energy and Ensco plc PR Newswire CHICAGO , Dec. 16, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog....
-
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners In "Neutraceutical Segments" & "Company Of The Year Award" Respectively at 4th Annual Pharmaceutical Leadership Awards 2011
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners In "Neutraceutical Segments" & "Company Of The Year Award" Respectively at 4th Annual Pharmaceutical Leadership Awards 2011 PR Newswire MUMBAI, India , December...
-
2012 Investment Outlook
2012 Investment Outlook PR Newswire LONDON , December 15, 2011 /PRNewswire/ -- The wealth managers' Christmas stocking: Russian commodities, Italian corporate bonds, Unilever, New York apartment blocks, and a gold bubble View...
-
Barchester Green Investment's Annual "Heroes and Villains" of ethical & environmental funds 2011
Dec 14, 2011 (PRN) : Barchester Green Investment| http://www.barchestergreen.co.uk , the UK’s leading independent financial adviser specialising in ethical and environmental investment, has announced its Heroes and Villains of 2011. Barchester’s...
-
Ogilvy PR Agrees to Acquire Mind Resource to Strengthen Regional Healthcare Communications Capabilities
Ogilvy PR Agrees to Acquire Mind Resource to Strengthen Regional Healthcare Communications Capabilities Underscores Confidence in Hong Kong's Growing Healthcare Market PR Newswire HONG KONG , Dec. 13, 2011 /PRNewswire/...
-
Global Sports and Fitness Nutrition Industry
Global Sports and Fitness Nutrition Industry PR Newswire NEW YORK , Dec. 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Sports and Fitness Nutrition Industry...
-
Stem Cell Therapeutics Announces Reorganization and Management Changes
New Commercial Focus on Licensing and Acquisition of Additional Stem Cell Technologies Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) today announced a corporate reorganization to reposition the company as the commercialization partner...
-
New Ernst & Young LLP Power & Utilities' Advisors to Specialize in Smart Grid and Customer Engagement
New Ernst & Young LLP Power & Utilities' Advisors to Specialize in Smart Grid and Customer Engagement PR Newswire DALLAS , Nov. 29, 2011 /PRNewswire/ -- Utilities across the globe are expected to invest as much as $200...
-
Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives
Sustainability in the Global Medical Devices Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Medical Devices Industry Procurement and Marketing Initiatives PR Newswire NEW YORK , Nov. 23, 2011...
-
Global Companion Diagnostics Industry
Global Companion Diagnostics Industry PR Newswire NEW YORK , Nov. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Companion Diagnostics Industry http://www.reportlinker.com/p0681905/Global-Companion-Diagnostics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnosti...
-
Horizon Pharma Adds Two New Biopharmaceutical Executives to Its Board of Directors
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the appointments of Michael Grey and Ronald Pauli to the Company's Board of Directors. "We are pleased to welcome Mike and Ron to our board. Their extensive pharma and biopharmaceutical experience...
-
GlaxoSmithKline and Amicus Therapeutics commence second phase III study of Amigal™ for Fabry disease
Issued: Monday 12 September 2011, London UK and Cranbury, New Jersey, US GlaxoSmithKline (GSK) and Amicus Therapeutics today announced the first patient has commenced dosing in a Phase III global registration study (Study 012) to compare...
Follow us
What people say
Our Partners
© 2005-2012